Aims Guidelines emphasize the importance of quadruple therapy in heart failure with reduced ejection fraction (HFrEF), and of achieving target doses quickly. The aim of the MAR-HF-Titration Study was to assess the effectiveness of a nurse-led, telemedicine program for this purpose. Methods and Results Prospective study including 210 HFrEF patients between September 2021 and December 2023. The 6-month follow-up used a telemedicine program involving daily telemonitoring of vital signs, weight and symptoms, routine laboratory test monitoring, videoconferences and the use of algorithms for drug titration. Mean age was 70 years, 35% women. Mean left ventricle ejection fraction (LVEF) was 31%, 60% had a non-ischemic etiology, and 61% newly diagnosed HF. After the intervention, significant increases were achieved in the use of quadruple therapy at any dose (63% vs 75%; p=0.001), at ≥50% of the target doses of each drug (10% vs 44%, p<0.001), and at target doses of all drugs (0% vs 19%, p<0.001). Median titration time was 45 days for betablockers, 65 for MRA, and 69 for ARNI. Older age, chronic kidney disease, hypotension, and higher NT-proBNP were associated with lower odds of effective titration. The LVEF increased (31% to 45%, p<0.001) and the NT-proBNP values were significantly reduced (1960 to 806 pg/ml, p<0.001). Increases in the use of prognostic medications were also observed in a sub-analysis restricted to participants aged ≥75 years. Conclusion Our intensive, nurse-led, telemedicine-based program attained a fast optimization of prognostic therapies in HFrEF and resulted in significant improvements in parameters with prognostic relevance.
No takes yet. Share an insight, caveat, or question.
Ruiz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: